Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 5/12/18 → 5/12/23 |
A 2-year prospective study to evaluate the onset of action of Mavenclad in subjects with highly active relapsing multiple sclerosis.
- Skibina, Olga (Primary Chief Investigator (PCI))
- O'Brien, Terence (Chief Investigator (CI))
Project: Research